Post by Bristol Myers Squibb
1,912,527 followers
Our researchers are pushing the boundaries of what's possible in cancer research — targeting and removing the proteins that fuel cancer growth with greater precision than ever before. Advancing multiple approaches to get rid of target proteins means we can better match therapies to disease biology, pushing the boundaries of what’s possible in blood cancers and solid tumors See how targeted protein degradation is opening new doors in oncology and hematology: https://bit.ly/3OrtoS7 #AACR26 #ScienceFirsthand #OneBMS
Video Content